HIV Patients with Cancer Face Longer Travel Distances for Clinical Trials
Audio narration · Coming soon
This report highlights that people living with HIV who also have cancer must travel farther than other patients to access clinical trials. This disparity suggests potential barriers in healthcare access for this group, impacting their treatment opportunities.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews
